CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-21 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −6,875 | 6,875 | ||
| 2022-02-21 | POPS RICHARD F Director and CEO, Alkermes plc | Option exercise | +32,400 | 879,942 | ||
| 2022-02-21 | POPS RICHARD F Director and CEO, Alkermes plc | Shares withheld for taxes | −14,386 | $25.08 | $361K | 865,556 |
| 2022-02-21 | POPS RICHARD F Director and CEO, Alkermes plc | Option exercise · Restricted Stock Unit Award | −32,400 | 32,400 | ||
| 2022-02-21 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,825 | 231,812 | ||
| 2022-02-21 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −2,587 | $25.08 | $65K | 229,225 |
| 2022-02-21 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −5,825 | 5,825 | ||
| 2022-02-21 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +4,800 | 82,618 | ||
| 2022-02-21 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −1,412 | $25.08 | $35K | 81,206 |
| 2022-02-21 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −4,800 | 4,800 | ||
| 2022-02-21 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise | +6,875 | 94,645 | ||
| 2022-02-21 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,022 | $25.08 | $51K | 92,623 |
| 2022-02-21 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −6,875 | 6,875 | ||
| 2022-02-21 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +4,800 | 56,398 | ||
| 2022-02-21 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −1,412 | $25.08 | $35K | 54,986 |
| 2022-02-21 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −4,800 | 4,800 | ||
| 2022-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +10,096 | 19,592 | ||
| 2022-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −2,966 | $25.08 | $74K | 16,626 |
| 2022-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −10,096 | 20,191 | ||
| 2022-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +3,824 | 22,362 |
Page 54 of 60 · 1,194 trades